| Dr Catherine Blake, AUD | |
|
216 Engle St Ste 101, Englewood, NJ 07631-2428 | |
| (201) 816-9800 | |
| (201) 567-1569 |
| Full Name | Dr Catherine Blake |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 7 Years |
| Location | 216 Engle St Ste 101, Englewood, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306312947 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 41YA00097500 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Englewood Ear Nose And Throat Pc | 6002900701 | 6 |
News Archive
GeneGo, Inc., the leading systems biology tools company, announced today that Millipore Corporation has sponsored academic groups from University of Queensland, Sheffield and USC to become members of the collaborative MetaMiner (Stem Cells) project run by GeneGo. MetaMiner is a partnership program for the reconstruction of stem cell pathways and their application in analysis of experimental data as well as knowledge mining.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced financial results for the third quarter ended September 30, 2011.
Although it is a "bit risky to herald progress during a global pandemic when infections of a disease such as AIDS still seem to multiply by the millions," the President's Emergency Plan for AIDS Relief gives the U.S. a "record that is worth celebrating, if only to show others around the world what's possible," a Wilmington News Journal editorial says.
Teva Pharmaceutical Industries Ltd. and Active Biotech today presented data further illuminating the novel, dual mechanism of action (MOA) of investigational oral, once-daily, laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS), conferring neuroprotective and anti-inflammatory properties.
Cough medicine could be used as way of predicting how well individual patients metabolise tamoxifen used in the treatment of their breast cancer, according to new research presented at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin today
› Verified 3 days ago
| Provider Name | Englewood Ear Nose & Throat Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1922208875 PECOS PAC ID: 6002900701 Enrollment ID: O20070925000392 |
News Archive
GeneGo, Inc., the leading systems biology tools company, announced today that Millipore Corporation has sponsored academic groups from University of Queensland, Sheffield and USC to become members of the collaborative MetaMiner (Stem Cells) project run by GeneGo. MetaMiner is a partnership program for the reconstruction of stem cell pathways and their application in analysis of experimental data as well as knowledge mining.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced financial results for the third quarter ended September 30, 2011.
Although it is a "bit risky to herald progress during a global pandemic when infections of a disease such as AIDS still seem to multiply by the millions," the President's Emergency Plan for AIDS Relief gives the U.S. a "record that is worth celebrating, if only to show others around the world what's possible," a Wilmington News Journal editorial says.
Teva Pharmaceutical Industries Ltd. and Active Biotech today presented data further illuminating the novel, dual mechanism of action (MOA) of investigational oral, once-daily, laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS), conferring neuroprotective and anti-inflammatory properties.
Cough medicine could be used as way of predicting how well individual patients metabolise tamoxifen used in the treatment of their breast cancer, according to new research presented at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin today
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Catherine Blake, AUD 216 Engle St Ste 101, Englewood, NJ 07631-2428 Ph: (201) 816-9800 | Dr Catherine Blake, AUD 216 Engle St Ste 101, Englewood, NJ 07631-2428 Ph: (201) 816-9800 |
News Archive
GeneGo, Inc., the leading systems biology tools company, announced today that Millipore Corporation has sponsored academic groups from University of Queensland, Sheffield and USC to become members of the collaborative MetaMiner (Stem Cells) project run by GeneGo. MetaMiner is a partnership program for the reconstruction of stem cell pathways and their application in analysis of experimental data as well as knowledge mining.
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced financial results for the third quarter ended September 30, 2011.
Although it is a "bit risky to herald progress during a global pandemic when infections of a disease such as AIDS still seem to multiply by the millions," the President's Emergency Plan for AIDS Relief gives the U.S. a "record that is worth celebrating, if only to show others around the world what's possible," a Wilmington News Journal editorial says.
Teva Pharmaceutical Industries Ltd. and Active Biotech today presented data further illuminating the novel, dual mechanism of action (MOA) of investigational oral, once-daily, laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS), conferring neuroprotective and anti-inflammatory properties.
Cough medicine could be used as way of predicting how well individual patients metabolise tamoxifen used in the treatment of their breast cancer, according to new research presented at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin today
› Verified 3 days ago
Lisa H Bernholz-balsam, MS, CCC-SLP/A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 214 Engle St, Suite 12, Englewood, NJ 07631 Phone: 201-871-5900 Fax: 201-871-0059 | |
Vicki Greenberg, MA, FAA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 200 Engle St, Suite 17, Englewood, NJ 07631 Phone: 201-567-1845 Fax: 201-567-0370 | |
Dr. Elizabeth Kathryn Nemec, M.S., MPH, AUD. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 177 N Dean St, Englewood, NJ 07631 Phone: 201-567-2771 Fax: 201-567-5052 | |
Dr. Jennifer Anna Douglas, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 177 N Dean St, Englewood, NJ 07631 Phone: 201-567-2771 | |
Audiology Services Company Usa, Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 300 Grand Ave Ste P2, Englewood, NJ 07631 Phone: 732-424-0445 | |
Dr. Yonah M Orlofsky, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 23 W Palisade Ave, Englewood, NJ 07631 Phone: 201-408-4441 |